Navigation Links
ViroPharma Receives Complete Response Letter for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Supplement
Date:10/22/2010

EXTON, Pa., Oct. 22 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding Cinryze™ (C1 Esterase Inhibitor [Human]) industrial scale manufacturing expansion activities. The FDA has requested additional information related to observations from the pre-approval inspection and review of the technical processes.  

"We and our partner Sanquin will begin working immediately to respond to the FDA as expeditiously as possible," said Vincent Milano, ViroPharma's president and chief executive officer.  "And, we plan to commence manufacturing industrial scale lots at risk in the first quarter of 2011."  

Continued Milano, "We remain committed to provide patients with an uninterrupted supply of Cinryze.  In addition to our efforts around our industrial scale, we expect our currently approved manufacturing process alone will yield up to 60,000 doses annually."

Conference Call and Webcast

ViroPharma is hosting a brief live teleconference and webcast with senior management on October 22, 2010 at 11:00 a.m. Eastern. To participate in the conference call, please dial (888) 299-4099 (domestic) and (302) 709-8337 (international).  After placing the call, please tell the operator you wish to join the ViroPharma investor conference call.  

Alternatively, the live webcast of the conference call can be accessed via ViroPharma's website at http://www.viropharma.com.  Windows Media or Real Player will be needed to access the webcast.  An audio archive will be available at the same address until November 5, 2010.

About Cinryze™ (C1 esterase inhibitor [human])

Cinryze is a highly purified, pasteurized and nanofiltered plasma-derived C1
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... HOUSTON , March 31, 2015 ... at the American Association of Orthodontics 2015 Annual ... leading orthodontists present scientific lectures on AcceleDent ® ... the leader in accelerated orthodontics, AcceleDent is a ... orthodontic treatment by as much as 50 percent ...
(Date:3/31/2015)... Pa. , March 31, 2015 ... against the board of directors of Hyperion Therapeutics, Inc. ... possible breaches of fiduciary duty and other violations of ... Company to Horizon Pharma plc in a transaction valued ... shares of Hyperion and would like to learn more ...
(Date:3/31/2015)... Ill. , March 31, 2015 ... ® Motion™-15-Days and Invia ® Motion™-Endure ... portfolio of products and services. These new devices, ... reflect Medela,s continued commitment to provide innovative, high-quality ... advanced wound treatment to patients. "We ...
Breaking Medicine Technology:Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3Ryan & Maniskas, LLP Announces Investigation of Hyperion Therapeutics, Inc. 2Medela Launches Product Line to Support Individualized Care For Negative Pressure Wound Therapy Patients 2
... Oct. 29 Stryker Corporation (NYSE: SYK ... a division of Porex Corporation. Porex Surgical is a ... (PPE) for use primarily in reconstructive surgery of the ... the PPE market with strong brand recognition and considerable ...
... LEIDEN, Netherlands, Oct. 29 Pursuant to the provisions of ... Takeover Bids (Besluit Openbare Biedingen Wft) requiring a public announcement ... offer to provide a status update, Johnson & Johnson (NYSE: ... CRXL ; Swiss Exchange: CRX) provide the following ...
Cached Medicine Technology:Stryker Announces Acquisition of Privately-Held Porex Surgical 2Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 2Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 3Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 4Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 5
(Date:3/31/2015)... Dr. St. Ledger recently returned from yet another trip ... Here, he participated in the Worn Dentition Workshop: a ... in cases of severely worn teeth, as well as the ... correlation to GERD and Sleep Apnea. , Dr. ... After the workshop he attended, he mentored for three days ...
(Date:3/31/2015)... March 31, 2015 Healthpointe’s team of ... at all of their clinics. Specialties include hip dislocations, ... , For athletes with hip injuries, Healthpointe has a ... and treat the symptoms and underlying causes of the ... care and prevent future damage, while taking into consideration ...
(Date:3/31/2015)... March 31, 2015 Beckman Coulter is sponsoring ... USP 787: “Subvisible Particulate Matter in Therapeutic Protein Injections”,” an ... new demands in counting particles in liquids, with a focus ... webinar is free to attend and will be broadcast live ... posted a new test for protein-based materials, known as ...
(Date:3/31/2015)... Fredericton, NB (PRWEB) March 31, 2015 Indosoft, ... than a decade, announce the availability of SIP over TCP ... their flagship software suite, offering a full contact center ... all over the world. Adding SIP over TCP support to ... to this system. , The history of Voice over IP ...
(Date:3/31/2015)... Greenfield Senior continues to build ... ("Care") a seniors housing-focused real estate investment and ... today, their acquisition of six senior housing communities ... Concurrent with the acquisition, Care will master lease ... ("Greenfield"). Pursuant to the lease, Care will provide ...
Breaking Medicine News(10 mins):Health News:The dentists at Upper Montclair Dental Associates are happy to announce exciting new happenings at their practice. 2Health News:Healthpointe Now Treating Hip Dislocations, Hip Fractures, Hip Bursitis, and Hip Strains at Locations in Southern California 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 3Health News:Indosoft extends SIP over TCP support to User Extensions in its Q-Suite 5.9 Call Center Software 2Health News:Greenfield Senior Living Inc. Enters Lease Transaction with Care Investment Trust LLC 2Health News:Greenfield Senior Living Inc. Enters Lease Transaction with Care Investment Trust LLC 3
... Center at Jefferson in Philadelphia have shown that by ... cells from metastatic dissemination. The work opens the door ... for therapies aimed at keeping prostate cancer at bay. ... laboratory and animal models, Marja Nevalainen, M.D., Ph.D., associate ...
... First- and Late-Line Treatment of NSCLC, CHICAGO, June ... from three clinical trials of XL647, a novel small ... Annual Meeting of the,American Society of Clinical Oncology (ASCO). ... untreated, clinically selected non-small cell,lung cancer (NSCLC) patients show ...
... Technologies Inc., a,leading developer and manufacturer of ... the company has entered into a,multi-million dollar ... multi- year exclusive agreement for cardiac Optical ... lasers for LightLab,s,next generation OCT imaging system., ...
... Funds to support product development and clinical ... 2 Cantimer, Inc., a privately,held company ... with applications in life science, biodefense, environmental,testing, ... announced,that it has been awarded a $996,000 ...
... DIEGO, June 2 Imagenetix, Inc. (OTC,Bulletin Board: ... a business,relationship with MonaVie LLC (http://www.monavie.com ) ... Active., Celadrin, a cellular lubricant, is a ... comfort. Providing continuous,lubrication, Celadrin improves cell membrane fluidity ...
... Treating pancreatic cancer with a combination of chemotherapy, ... may be beneficial for patients, according to a University ... 44th annual meeting of the American Society of Clinical ... physicians from the Pancreatic Cancer Center of the University ...
Cached Medicine News:Health News:Blocking signaling protein prevents prostate cancer spread, Jefferson scientists find 2Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 2Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 3Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 4Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 5Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 6Health News:Axsun Technologies Announces Exclusive Cardiac Supply Agreement for Advanced OCT Tunable Lasers with LightLab Imaging 2Health News:Cantimer, Inc. Awarded $996,000 Contract from U.S. Government to Develop Portable, Real-Time and Non-Invasive Hydration Measurement and Monitoring System for Use by Firefighters 2Health News:Imagenetix Enters into Business Relationship with MonaVie 2Health News:New treatment combination safe for pancreatic cancer patients 2
... and custom shields and barriers for superior radiation ... or high level radiation shielding, we have a ... lead acrylic, lead glass, lead vinyl or a ... offer shielding from 1/32" thick to 2" and ...
Height-Adjustable Mobile X-ray Barrier lets you get close to your patient during special procedures like cardiac cath. 24"H x 36"W viewing panel shields the upper body of one or two people and swivel...
Ball-and-socket center mount can rotate 360, allowing them to be turned hoirzontally, vertically, or at any angle. Very versatile! Available with or without torso placement contour cutout and in thre...
Wrap-Around, Full Protection Apron with BACK SUPPORT...
Medicine Products: